Treatment approach to connective tissue disease-associated interstitial lung disease

被引：13
|
作者：
Wilson, Timothy M. [1 ]
Solomon, Joshua J. [2 ]
Demoruelle, M. Kristen [1 ]
机构：
[1] Univ Colorado Denver, Div Rheumatol, Aurora, CO 80204 USA
[2] Natl Jewish Hlth, Div Pulm Crit Care & Sleep Med, Denver, CO USA
来源：
CURRENT OPINION IN PHARMACOLOGY | 2022年 / 65卷
基金：
美国国家卫生研究院;
关键词：
RHEUMATOID-ARTHRITIS; SYSTEMIC-SCLEROSIS; DOUBLE-BLIND; DERMATOMYOSITIS; MORTALITY; SURVIVAL; CYCLOPHOSPHAMIDE; MANIFESTATIONS; INTERLEUKIN-6; TOCILIZUMAB;
D O I：
10.1016/j.coph.2022.102245
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Interstitial lung disease (ILD) is a common manifestation in connective tissue diseases (CTD), such as rheumatoid arthritis (RA), systemic sclerosis (SSc), and inflammatory myositis (IM). ILD is associated with significant morbidity and mortality in nearly all CTD highlighting the critical need for effective treatment strategies in this patient population. In this review, we will summarize the approach to treatment when there is concern for CTD-ILD and highlight recent advancements in therapeutics within various forms of CTD-ILD.
引用
收藏
页数：6
相关论文
共 50 条
  • [1] Current approach to connective tissue disease-associated interstitial lung disease
    Solomon, Joshua J.
    Chartrand, Sandra
    Fischer, Aryeh
    CURRENT OPINION IN PULMONARY MEDICINE, 2014, 20 (05) : 449 - 456
  • [2] Diagnosis and Treatment of Connective Tissue Disease-Associated Interstitial Lung Disease
    Vij, Rekha
    Strek, Mary E.
    CHEST, 2013, 143 (03) : 814 - 824
  • [3] RITUXIMAB FOR THE TREATMENT OF CONNECTIVE TISSUE DISEASE-ASSOCIATED INTERSTITIAL LUNG DISEASE
    Chartrand, Sandra
    Swigris, Jeffrey J.
    Peykova, Lina
    Fischer, Aryeh
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2015, 32 (04) : 296 - 304
  • [4] Connective tissue disease-associated interstitial lung disease
    Storrer, Karin Mueller
    Mueller, Carolina de Souza
    de Albuquerque Pessoa, Maxwell Cassio
    de Castro Pereira, Carlos Alberto
    JORNAL BRASILEIRO DE PNEUMOLOGIA, 2024, 50 (01)
  • [5] Connective tissue disease-associated interstitial lung disease
    Oliveira, R. P.
    Ribeiro, R.
    Melo, L.
    Grima, B.
    Oliveira, S.
    Alves, J. D.
    PULMONOLOGY, 2022, 28 (02): : 113 - 118
  • [6] Connective Tissue Disease-Associated Interstitial Lung Disease
    Fischer, Aryeh
    Brasington, Richard D.
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2015, 11 (02) : 72 - 72
  • [7] New treatment paradigms for connective tissue disease-associated interstitial lung disease
    Kouranos, Vasileios
    Miranda, Gina
    Corte, Tamera J.
    Renzoni, Elisabetta A.
    CURRENT OPINION IN PULMONARY MEDICINE, 2018, 24 (05) : 453 - 460
  • [8] Rituximab Treatment For Chronic Connective Tissue Disease-Associated Interstitial Lung Disease
    Chartrand, S.
    Swigris, J. J.
    Peykova, L.
    Fischer, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [9] The role of biologics in treatment of connective tissue disease-associated interstitial lung disease
    Sharp, C.
    Dodds, N.
    Mayers, L.
    Millar, A. B.
    Gunawardena, H.
    Adamali, H.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2015, 108 (09) : 683 - 688
  • [10] Imaging in connective tissue disease-associated interstitial lung disease
    Rao, Praveen R. G.
    Joshi, Kushal
    Liyanage, Sidath
    Dalili, Daniel
    Koduri, Gouri
    INDIAN JOURNAL OF RHEUMATOLOGY, 2021, 16 (05) : 58 - 68
12345